2don MSN
Parallel microdevice with AI-powered single-cell analysis enables rapid, high-throughput delivery
Many applications—from drug discovery and diagnostics to cell engineering and gene modulation—require delivering biomolecules ...
Coronary artery bypass graft (CABG) surgery remains the gold standard treatment for patients with severe atherosclerosis, but ...
If you have been following AbbVie (ABBV), the company’s latest move might sway your decision on whether to stick with or jump ...
Regeneron's Evkeeza gains FDA approval for treating young children with homozygous familial hypercholesterolemia, addressing ...
Registration Link Below for September 30, 2025 12 PM EST Presentation and Live Q&AKing of Prussia, Pennsylvania--(Newsfile ...
Scripps professor Sumit Chanda says improving coronavirus care is especially important to get ahead of any future mutations ...
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary ...
In this interview, Dr. Freya Leech, a researcher at NanoFCM, discusses the current challenges and future prospects in ...
Takeda offers a compelling investment case with six late-stage therapies targeting $20 billion in peak sales by 2030-31.
Total investments of $14 million by CTI, the Fonds de solidarité FTQ, and Investissement Québec MONTRÉAL, Sept. 23, 2025 /CNW/ – CTI Life Sciences Fund (CTI) has launched Oligon ...
Pireezidaantiin Keeniyaa Wiliyaam Ruutoo eebba hidha haaromsa guddicha Itoophiyaa irratti argamuutti mufachuu Keeniyaatti ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback